10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $283,000 | -6.9% | 9,948 | +148.7% | 0.01% | -18.2% |
| Q1 2022 | $304,000 | -35.5% | 4,000 | +26.5% | 0.01% | -45.0% |
| Q4 2021 | $471,000 | +79.8% | 3,162 | +136.5% | 0.02% | +150.0% |
| Q2 2021 | $262,000 | -64.4% | 1,337 | -74.3% | 0.01% | -52.9% |
| Q4 2020 | $736,000 | -20.3% | 5,200 | -29.7% | 0.02% | -10.5% |
| Q3 2020 | $923,000 | +158.5% | 7,400 | +85.0% | 0.02% | +137.5% |
| Q2 2020 | $357,000 | +20.2% | 4,000 | +2.7% | 0.01% | +300.0% |
| Q4 2019 | $297,000 | – | 3,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |